Achieving a molecular diagnosis provides the most comprehensive understanding of a patient's primary immune dysregulation, allowing for tailored interventions and personalized surveillance strategies. The diagnostic process to uncover a molecular etiology, however, can be complicated by numerous testing strategies and modalities, each with their own nuances and limitations. Nevertheless, this trend toward precision medicine requires us to navigate the genetic testing landscape to ultimately improve health outcomes in our patients.